BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9637266)

  • 1. Expression of bcl-2 in fetal thymus, thymomas and thymic carcinomas. Association with p53 expression and review of the literature.
    Engel P; Francis D; Graem N
    APMIS; 1998 Apr; 106(4):449-55. PubMed ID: 9637266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53, mdm2, p21/waf1 and bcl-2 proteins in thymomas.
    Stefanaki K; Rontogianni D; Kouvidou CH; Bolioti S; Delides G; Pantelidaki A; Sotsiou F; Kanavaros P
    Histopathology; 1997 Jun; 30(6):549-55. PubMed ID: 9205859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
    Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
    Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of epidermal and nerve growth factor receptors in human thymus and thymomas.
    Pescarmona E; Pisacane A; Pignatelli E; Baroni CD
    Histopathology; 1993 Jul; 23(1):39-44. PubMed ID: 8365713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors.
    Tateyama H; Eimoto T; Tada T; Inagaki H; Hattori H; Takino H
    Mod Pathol; 1997 Oct; 10(10):983-91. PubMed ID: 9346177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
    Dorfman DM; Shahsafaei A; Miyauchi A
    Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
    Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histo-blood group antigens in human fetal thymus and in thymomas.
    Engel P; Dabelsteen E; Francis D; Graem N
    APMIS; 1996 Oct; 104(10):741-9. PubMed ID: 8980625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of Mcl-1 and bcl-2 proteins in thymic epithelial tumours.
    Chen FF; Yan JJ; Chang KC; Lai WW; Chen RM; Jin YT
    Histopathology; 1996 Dec; 29(6):541-7. PubMed ID: 8971561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.
    Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H
    Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of bcl-2 protein in thymoma.
    Brocheriou I; Carnot F; Briere J
    Histopathology; 1995 Sep; 27(3):251-5. PubMed ID: 8522289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness.
    Chen FF; Yan JJ; Jin YT; Su IJ
    Hum Pathol; 1996 Oct; 27(10):1089-92. PubMed ID: 8892596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Bcl-2 protein in the myasthenic thymus.
    Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
    Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The level of Bcl-2 and Fas expression in thymoma tissue from patients with myasthenia gravis].
    Shen G; Chai Y; Yue L; Wei HQ; Lin M
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr; 29(4):240-2. PubMed ID: 16750039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin profiles of the thymus and thymomas: histogenetic correlations and proposal for a histological classification of thymomas.
    Kuo Tt
    Histopathology; 2000 May; 36(5):403-14. PubMed ID: 10792481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
    Hattori H; Tateyama H; Tada T; Saito Y; Yamakawa Y; Eimoto T
    Virchows Arch; 2000 Jan; 436(1):20-7. PubMed ID: 10664158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of Epstein-Barr virus, cell proliferation and apoptosis in thymic tumors].
    Mai S; Xiong M; Zong Y; Li Z; Rao H
    Zhonghua Bing Li Xue Za Zhi; 1999 Apr; 28(2):89-92. PubMed ID: 11869513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms.
    Datta MW; Shahsafaei A; Nadler LM; Freeman GJ; Dorfman DM
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):210-5. PubMed ID: 10981873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen.
    Gilhus NE; Jones M; Turley H; Gatter KC; Nagvekar N; Newsom-Davis J; Willcox N
    J Clin Pathol; 1995 May; 48(5):447-55. PubMed ID: 7629292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p63 in thymomas and normal thymus.
    Dotto J; Pelosi G; Rosai J
    Am J Clin Pathol; 2007 Mar; 127(3):415-20. PubMed ID: 17276940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.